This inventor holds 2 USPTO granted patents. Top assignee: The Dupont Merck Pharmaceutical Company. Active years: 1991-1992.
Company Filing History:
Years Active: 1991-1992
Title: The Innovations of Stephen W. Wright
Introduction
Stephen W. Wright is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that focus on innovative compounds and their applications in treating various disorders.
Latest Patents
Wright's latest patents include "Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase." This invention relates to vinylogous hydroxamic acids, processes for their manufacture, pharmaceutical preparations containing them, and their use in the treatment of various disorders. Another significant patent is for "Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives." This patent describes compounds that are useful for treating inflammatory diseases in mammals.
Career Highlights
Stephen W. Wright is associated with the DuPont Merck Pharmaceutical Company, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the creation of innovative treatments that address critical health issues.
Collaborations
Wright has collaborated with notable colleagues such as Ronald L. Magolda and Douglas G. Batt, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Stephen W. Wright's contributions to pharmaceutical innovation through his patents and collaborations highlight his role as a key figure in the field. His work continues to influence the development of new treatments for various health conditions.